SCHEMBL23292014

SCHEMBL23292014

Oc1cccnc1-c1ccc2nncn2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.49
MAPK14 Q16539 1/20 0.46
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
KMT2A Q03164 1/20 0.44
SCN5A Q14524 1/20 0.43
TGFBR1 P36897 1/20 0.41
ADORA2A P29274 4/20 0.39
ADORA2B P29275 3/20 0.39
ADORA1 P30542 3/20 0.39
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
HSD17B10 Q99714 1/20 0.37
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
LRRK2 Q5S007 2/20 0.35
MLLT1 Q03111 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30557195 1.00 DNMT1 (0.49) DNMT1MAPK14KDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL30557306 0.98 DNMT1 (0.48) DNMT1MAPK14KDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL23292102 0.98 DNMT1 (0.48) DNMT1MAPK14KDM4EALDH1A1HPGD
SCHEMBL11018883 0.75 DNMT1 (0.51) DNMT1MAPK14KDM4ESCN5ATGFBR1
SCHEMBL15639155 0.75 DNMT1 (0.48) DNMT1MAPK14SCN5ATGFBR1ADORA2A
SCHEMBL10957958 0.72 DNMT1 (0.51) DNMT1MAPK14KDM4EALDH1A1HPGD
SCHEMBL11379662 0.72 SCN5A (0.59) DNMT1MAPK14ALDH1A1SCN5ATGFBR1
SCHEMBL1500118 0.71 GRM1 (0.59) DNMT1MAPK14SCN5ATGFBR1ADORA2A
SCHEMBL15639173 0.71 TGFBR1 (0.48) DNMT1MAPK14ALDH1A1SCN5ATGFBR1
SCHEMBL15639501 0.69 TGFBR1 (0.44) DNMT1MAPK14SCN5ATGFBR1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3814360-A1 HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC Therapeutics, Inc. (US) 2021-05-05 EP claimed